Amrize Ltd (NYSE:AMRZ) Short Interest Update

Amrize Ltd (NYSE:AMRZ) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 9,949,657 shares, a decrease of 12.7% from the December 31st total of 11,399,098 shares. Currently, 1.8% of the company’s shares are short sold. Based on an average trading volume of 3,048,373 shares, the days-to-cover ratio is presently 3.3 days. Based on an average trading volume of 3,048,373 shares, the days-to-cover ratio is presently 3.3 days. Currently, 1.8% of the company’s shares are short sold.

Amrize Price Performance

Shares of Amrize stock opened at $52.95 on Tuesday. Amrize has a 1 year low of $44.12 and a 1 year high of $58.11. The stock has a 50-day moving average price of $54.31. The company has a market cap of $29.29 billion and a PE ratio of 28.78. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Sanford C. Bernstein reiterated an “outperform” rating and issued a $70.00 price objective on shares of Amrize in a report on Thursday, December 18th. Vertical Research began coverage on shares of Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price objective for the company. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Stephens initiated coverage on Amrize in a research report on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective for the company. Finally, Barclays started coverage on shares of Amrize in a report on Tuesday, October 7th. They set an “equal weight” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $60.75.

Insider Buying and Selling at Amrize

In other news, Director Nicholas C. Gangestad purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The stock was bought at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the acquisition, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. This represents a 67.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Hedge Funds Weigh In On Amrize

A number of hedge funds have recently added to or reduced their stakes in AMRZ. Sumitomo Mitsui DS Asset Management Company Ltd bought a new position in Amrize during the 4th quarter valued at about $2,937,000. Wilson Asset Management International PTY Ltd. raised its holdings in shares of Amrize by 8.3% during the fourth quarter. Wilson Asset Management International PTY Ltd. now owns 247,477 shares of the company’s stock valued at $13,384,000 after purchasing an additional 18,942 shares during the last quarter. Nordwand Advisors LLC lifted its position in Amrize by 2.0% during the fourth quarter. Nordwand Advisors LLC now owns 138,630 shares of the company’s stock valued at $7,497,000 after purchasing an additional 2,675 shares during the period. CENTRAL TRUST Co purchased a new stake in Amrize in the fourth quarter worth approximately $271,000. Finally, Composition Wealth LLC grew its position in Amrize by 1.3% in the 4th quarter. Composition Wealth LLC now owns 134,205 shares of the company’s stock worth $7,258,000 after purchasing an additional 1,774 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.